Vascular endothelial growth factor (VEGF) inhibitors can suppress neo-angiogenesis in malignancy and are widely used as an anti-neoplastic treatment for many solid tumors, including non-small cell lung cancer, breast cancer, and colorectal cancer [1,2]. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.